Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

NCT01359462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Cirrhosis
Ascites

Interventions

DRUG: tolvaptan

Sponsor

Otsuka Beijing Research Institute